Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256554 · ClinicalTrials.gov registry record · Phase 1
Single Session Spine Stereotactic Radiosurgery in Metastatic Epidural Spinal Cord Compression
A Phase 1 study of Metastatic Epidural Spinal Cord Compression, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT01256554 is a Phase 1 study of Metastatic Epidural Spinal Cord Compression that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 11 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01256554, a Phase 1 study of Metastatic Epidural Spinal Cord Compression, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical study is to learn the feasibility of using a single session of radiation, known as spine stereotactic radiosurgery (SSRS), to treat metastatic epidural spinal cord compression.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- PROCEDURE Stereotactic Radiosurgery (SSRS)
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2010-12-03 |
| Est. Completion | 2021-10-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01256554
The ClinicalTrials.gov registry entry for NCT01256554 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metastatic Epidural Spinal Cord Compression appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT01256554 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01256554 about?
NCT01256554 is a clinical study titled "Single Session Spine Stereotactic Radiosurgery in Metastatic Epidural Spinal Cord Compression". The goal of this clinical study is to learn the feasibility of using a single session of radiation, known as spine stereotactic radiosurgery (SSRS), to treat metastatic epidural spinal cord compression.
What is the current status of trial NCT01256554?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2010-12-03. Estimated completion is 2021-10-15.
What conditions does trial NCT01256554 study?
This clinical trial studies the following conditions: Metastatic Epidural Spinal Cord Compression.
What interventions are being tested in trial NCT01256554?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Stereotactic Radiosurgery (SSRS) (PROCEDURE).
Who is sponsoring clinical trial NCT01256554?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01256554 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Epidural Spinal Cord Compression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.